Drug Trial Radar · NCT07397325
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
May 16, 2026
Primary completion
Feb 5, 2027
Study completion Mar 5, 2027
Sponsor
- Lead sponsor
- Applied Biology, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Daniel Alain, Inc.; Follea International Limited
- First posted
- Feb 9, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Conditions
- Chemotherapy Induced Alopecia
- Chemotherapy Side Effects
Interventions
DA-020Drug
7mL application of DA-020 (Topical Oxymetazoline)
PlaceboDrug
Topical placebo solution
DA-020 and HyperforinDrug
7mL application of DA-020 (Topical Oxymetazoline) and Hyperforin (1.5%)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Prevention of Hair Loss (Common Terminology Criteria for Adverse Events V5.0)Time frame: Week [0,12]
Locations
2 sites in 2 countries. Site status is shown where the registry gives one.
Hospital Samel
Manaus, Brazil · Recruiting
University of Rome ("G. Marconi")
Rome, Italy · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.